Physician profile
James Muller
NPI 1669000386
$1,381.62
in general payments reported to CMS, 2019-2025
18 companies · $544 in 2025
The $544 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.91 · 2021: $169 · 2022: $346 · 2023: $268 · 2024: $41.20 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $335.29 | 2021-2025 | Airsupra, Breztri |
| Novo Nordisk INC | $253.96 | 2020-2025 | Ozempic, Rybelsus |
| Amgen INC. | $168.81 | 2021-2022 | |
| Axsome Therapeutics, INC. | $119.81 | 2025 | Symbravo, Auvelity |
| Pfizer INC. | $83.91 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.56 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.91 | 2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $49.63 | 2023 | |
| Exact Sciences Corporation | $39.79 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $39.77 | 2024-2025 | Nexplanon |
| Abbvie INC. | $38.84 | 2021 | |
| Gilead Sciences, INC. | $31.81 | 2021-2025 | |
| Dexcom, INC. | $29.66 | 2021 | |
| Daiichi Sankyo INC. | $19.78 | 2023 | Injectafer |
| Lilly USA, LLC | $16.72 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $16.58 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $16.54 | 2022 | |
| Viiv Healthcare Company | $16.25 | 2023 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Muller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.